Founded in 2010 and based in Oslo, Norway, Birk Venture primarily invests in healthcare initiatives such as pharmaceuticals, biotechnology, diagnostics, and medical devices. The firm has made investments in companies like BerGenBio, Nordic Nanovector, APIM Therapeutics, Nextera, Zelluna Immunotherapy, Onco Invent, and Targovax. They have also exited investments in companies like BerGenBio, Targovax, Algeta, Cortendo, and PCI Biotech. Birk Venture is known for its preference for investing in small-sized or start-up companies and has a particular interest in founders of portfolio startups who have been in business for 2-3 years.